Molecular heterogeneity in deficiency of complement protein C2 type I

Immunology

Volumn 93, Issue 2, 1998, Pages 184-191

  Wang, X ^a   Circolo, A ^a   Lokki, M L ^a,c   Shackelford, P G ^a   Wetsel, R A ^a,b   Colten, H R ^a,d  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c FINNISH RED CROSS BLOOD SERVICE   (Finland)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DNA FLANKING REGION; FRAMESHIFT MUTATION; GENE DELETION; GENETIC ANALYSIS; HAPLOTYPE; MAJOR HISTOCOMPATIBILITY COMPLEX; MISSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BACTEREMIA; BASE SEQUENCE; BLOTTING, NORTHERN; CELL CULTURE TECHNIQUES; CHILD; COMPLEMENT C2; COMPLEMENT FACTOR B; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; OPPORTUNISTIC INFECTIONS; PEDIGREE; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; RECURRENCE; RNA, MESSENGER;

EID: 0031934956     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00392.x     Document Type: Article

References (44)

1. COLTEN H.R. & ROSEN F.S. (1992) Complement deficiencies. Annu Rev Immunol 10, 809.
2. MORGAN B.P. & WALPORT M.J. (1991) Complement deficiency and disease. Immunol Today 12, 301.
3. FIGUEROA J.E. & DENSEN P. (1991) Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4, 359.
4. WESSELS M.R., BUTKO P., MA M., WARREN H.B., LAGE A.L. & CARROLL M.C. (1995) Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 92, 11 490.
5. MOLINA H., HOLERS V.M., LI B. et al. (1996) Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93, 3357.
6. FISCHER M.B., MA M., GOERG S. et al. (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157, 549.
7. MATSUMOTO M., FUKUDA W., CIRCOLO A. et al. (1997) Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci USA 94, 8720.
8. ISHIKAWA N., NONAKA M., WETSEL R.A. & COLTEN H.R. (1990) Murine complement C2 and factor B genomic and cDNA cloning reveals different mechanisms for multiple transcripts of C2 and B. J Biol Chem 265, 19 040.
9. ISHII Y., ZHU Z.B., MACON K.J. & VOLANAKIS J.E. (1991) Structure of the gene for human complement component C2 (abstract). Compl Inflamm 8, 167.
10. CARROLL M.C., CAMPBELL R.D., BENTLEY D.R. & PORTER R.R. (1984) A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307, 237.
11. FU S.M., KUNKEL H.G., BRUSMAN H.P., ALLEN F.H. & FOTINO M. (1974) Evidence for linkage between HLA histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med 140, 1108.
12. PERLMUTTER D.H., COLTEN H.R., GROSSBERGER D., STROMINGER J., SEIDMAN J.G. & CHAPLIN D.D. (1985) Expression of complement proteins C2 and factor B in transfected L-cells. J Clin Invest 76, 1449.
13. GLASS D., RAUIM D., GIBSON D., STILLMAN J.S. & SCHUR P. (1976) Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest 58, 853.
14. TRUEDSSON L., ALPER C.A., AWDEH Z.L., JOHANSEN P., SJOHOLM A.G. & STURFELT G. (1993) Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype HLA-B-region and absence of disease association due to linked class II genes. J Immunol 151, 5856.
15. JOHNSON C.A., DENSEN P., WETSEE R.A., COLE F.S., GOEKEN N.E. & COLTEN H.R. (1992) Molecular heterogeneity of C2 deficiency. N Engl J Med 326, 871.
16. JOHNSON C.A., DENSEN P., HURFORD R.K., COLTEN H.R. &. WETSEL R.A. (1992) Type I human complement C2 deficiency. A 28-base pair gene deletion causes skipping of exon 6 during RNA splicing. J Biol Chem 267, 9347.
17. 444→Arg) cause impaired C2 secretion. J Biol Chem 271, 5824.
18. ROONEY D.E. & ZEBULKOWSKI B.H. (1986) Tissue culture methods in human cytogenetics. In: Human Cytogenetics: A Practical Approach (eds. D. E. Rooney & B. H. Zebulkowski). pp. 1-37. JRL Press, Oxford.
19. KULICS J., CIRCOLO A., STRUNK R.C. & COLTEN H.R. (1994) Regulation of synthesis of complement protein C4 in human fibroblasts: cell- and gene-specific effects of cytokines and lipopolysaccharide. Immunology 82, 509.
20. MORRIS K.M., ADEN D.P., KNOWLES B.B. & COLTEN H.R. (1982) Complement biosynthesis in the human hepatoma-derived cell line HepG2. J Clin Invest 70, 906.
21. LAEMMLI U.K. (1970) Cleavage of the structural proteins during assembly of the head of bacteriophage T4. Nature (London) 227, 680.
22. CHIRGWIN J.M., PRZBYLA A.E., MACDONALD R.J. & RUTTER W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294.
23. WOODS D.E., MARKHAM A.F., RICKER A.T., GOLDBERGER G. & COLTEN H.R. (1982) Isolation of cDNA clones for the human complement protein factor B, a class III MHC gene product. Proc Natl Acad Sci USA 79, 5661.
24. WOODS D.E., EDGE M.D. & COLTEN H.R. (1984) Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism. J Clin Invest 74, 634.
25. SCHWARTZ R.J., HASA J.A., ROTHBLUM K.N. & DUGAICZYK A. (1980) Regulation of muscle differentiation: cloning sequences from alpha-actin messenger ribonucleic acid. Biochemistry 19, 5883.
26. HORIUCHI T., MACON K.J., KIDD V.J. & VOLANAKIS J.E. (1989) cDNA cloning and expression of human complement component C2. J Immunol 142, 2105.
27. BENTLEY D.R. (1986) Primary structure of human complement component C2. Homology to two unrelated protein families. Biochem J 239, 339.
28. NONAKA M., GITLIN J.D. & COLTEN H.R. (1989) Regulation of human and murine complement. Comparison of 5′ structural and functional elements regulating human and murine complement factor B gene expression. Molec Cellular Biochem 89, 1.
29. SATOH K., NUKIWA T., BRANTLY M. et al. (1988) Emphysema associated with complete absence of α1-antitrypsin of a stop codon in an α1-antitrypsin-coding exon. Am J Hum Genet 42, 77.
30. NOGEE M., GARNIER G., DIETZ H.C. et al. (1994) A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93, 1860.
31. HAMOSH A., TRAPNELL B.C., ZETTLEN P.L. et al. (1991) Severe deficiency of cystic fibrosis transmembrane conductance regulatory messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis. J Clin Invest 88, 1880.
32. BASERGA S. & BENZ E.J. JR (1988) Nonsense mutations in the human β-globin gene affect mRNA metabolism. Proc Natl Acad Sci USA 85, 2056.
33. URLAUB G., MITCHELL P.J., CIUDAD C.J. & CHASIN L.A. (1989) Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 9, 2868.
34. BELGRADER P., CHENG J. & MAQUAT L.E. (1993) Evidence to implicate translation by ribosomes in the mechanism by which nonsense codons reduce the nuclear level of human triosephosphate isomerase mRNA. Proc Natl Acad Sci USA 90, 482.
35. CHENG J. & MAQUAT L.E. (1993) Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half-life of cytoplasmic mRNA. Mol Cell Biol 13, 1892.
36. RUTZ-ECHEVARRIA M.J., CZAPLINSKI K. & PELTZ S.W. (1996) Making sense of nonsense in yeast. TIBS 21, 433.
37. LOSSON R. & LACROUTE F. (1979) Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 76, 5134.
38. NEWMAN S.L., VOGLER L.B., FEIGIN R.D. & JOHNSTON R.B. JR (1978) Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med 299, 290.
39. SCHWERTZ R., ESSER E., SEGER R.A., RUBINSTEIN A., HAUPTMANN G. & WAHN V. (1991) Defective activation of the alternative pathway of complement in patients with homozygous C2 deficiency: studies in two unrelated families. Eur J Pediatr 150, 647.
40. SANAL O., YEL L., TEZCAN I., ERSOY F. & BERKEL A.I. (1996) Homozygous C2 deficiency: Association with defective alternative pathway function and immunoglobulin deficiency. Intl Arch All Immunol 110, 195.
41. HAUPTMANN G. (1989) Frequency of complement deficiencies in man, disease associations and chromosome assignment of complement genes and linkage groups. Complement Inflamm 6, 74.
42. FIELDER A.H.L., WALPORT M.J., BATCHELOR H.R., RYNES R.I. & BLACK C.M. (1983) Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J 286, 425.
43. HOWARD P.F., HOCHBERG M.C., BIAS W.B., ARNETT F.C. JR & MCLEAN R.H. (1989) Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and Black Americans. Am J Med 81, 187.
44. KUMAR A., KUMAR P. & SCHUR P.H. (1991) DR3 and nonDR3 associated complement component C4A deficiency in systemic lupus erythematosus. Clin Immunol Immunopathol 60, 55.